. 2022 Dec 17;108(1):1-3.

doi: 10.1210/clinem/dgac547.

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Collaborators, Affiliations

Collaborators

Working Group for Renaming Diabetes Insipidus:
Hiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, Mark Gurnell, Deborah Cooper, Juliana Drummond, Miles Levy, Mark Gurnell, Ann McCormack, Joseph G Verbalis, John Newell-Price, John Wass

Affiliations

¹ Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
² Department of Pediatric Endocrinology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
³ Great North Children's Hospital (GNCH), Newcastle upon Tyne NE1 4LP, UK.
⁴ Department of Endocrinology, University Hospital and University of Basel, CH-4031 Basel, Switzerland.
⁵ The Pituitary Foundation, Bristol BS1 5BB, UK.
⁶ Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG CEP 31270-901, Brazil.
⁷ Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
⁸ Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, UK.
⁹ Department of Endocrinology, St Vincent's Hospital, Sydney, NSW 2010, Australia.
¹⁰ Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
¹¹ St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
¹² Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
¹³ Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA.
¹⁴ Department of Endocrinology, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.

PMID: 36355385
PMCID: PMC9759163
DOI: 10.1210/clinem/dgac547

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Hiroshi Arima et al. J Clin Endocrinol Metab. 2022.

. 2022 Dec 17;108(1):1-3.

doi: 10.1210/clinem/dgac547.

Authors

Collaborators

Working Group for Renaming Diabetes Insipidus:
Hiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, Mark Gurnell, Deborah Cooper, Juliana Drummond, Miles Levy, Mark Gurnell, Ann McCormack, Joseph G Verbalis, John Newell-Price, John Wass

Affiliations

¹ Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
² Department of Pediatric Endocrinology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
³ Great North Children's Hospital (GNCH), Newcastle upon Tyne NE1 4LP, UK.
⁴ Department of Endocrinology, University Hospital and University of Basel, CH-4031 Basel, Switzerland.
⁵ The Pituitary Foundation, Bristol BS1 5BB, UK.
⁶ Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG CEP 31270-901, Brazil.
⁷ Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
⁸ Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, UK.
⁹ Department of Endocrinology, St Vincent's Hospital, Sydney, NSW 2010, Australia.
¹⁰ Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
¹¹ St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
¹² Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
¹³ Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA.
¹⁴ Department of Endocrinology, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.

PMID: 36355385
PMCID: PMC9759163
DOI: 10.1210/clinem/dgac547

Abstract

Recent data show that patients with a diagnosis of diabetes insipidus (DI) are coming to harm. Here we give the rationale for a name change to arginine vasopressin deficiency and resistance for central and nephrogenic DI, respectively.

Keywords: arginine vasopressin deficiency; arginine vasopressin resistance; diabetes insipidus; nephrogenic; pituitary.

PubMed Disclaimer

Cited by

Desmopressin prescription safety in adult inpatients: a real-world tertiary centre experience.
Arshad MF, Solanki S, Dancyger-Stevens L, Karunanayaka M, Loh EW, Htoon KN, Turki M, Munir A. Arshad MF, et al. Endocr Connect. 2025 Feb 11;14(3):e240441. doi: 10.1530/EC-24-0441. Print 2025 Mar 1. Endocr Connect. 2025. PMID: 39854712 Free PMC article.
The changing landscape in the evaluation of hypotonic polyuria in children and adolescents: the role of the new copeptin stimulation tests.
Garibaldi LR, Sastry S, McPhaul MJ, March CA. Garibaldi LR, et al. J Pediatr Endocrinol Metab. 2025 May 23;38(7):703-717. doi: 10.1515/jpem-2025-0046. Print 2025 Jul 28. J Pediatr Endocrinol Metab. 2025. PMID: 40420740 Review.
Comparison of clinical and radiological characteristics of inflammatory and non-inflammatory Rathke cleft cysts.
Matsushita S, Shimono T, Maeda H, Tsukamoto T, Horiuchi D, Oura T, Ishibashi K, Takita H, Tatekawa H, Atsukawa N, Goto T, Miki Y. Matsushita S, et al. Jpn J Radiol. 2025 Jan;43(1):32-42. doi: 10.1007/s11604-024-01641-0. Epub 2024 Aug 20. Jpn J Radiol. 2025. PMID: 39162782 Free PMC article.
Diagnostic Pitfalls of a Newborn with Congenital Nephrogenic Diabetes Insipidus.
Güran Ö, Güven S, Kırmızıbekmez H, Akgün Doğan Ö, Karadeniz Bilgin L. Güran Ö, et al. J Clin Res Pediatr Endocrinol. 2025 Mar 19;17(1):91-96. doi: 10.4274/jcrpe.galenos.2023.2022-11-22. Epub 2023 Feb 23. J Clin Res Pediatr Endocrinol. 2025. PMID: 36815512 Free PMC article.
Phosphoproteomic response to epidermal growth factor in native rat inner medullary collecting duct.
Chou CL, Jayatissa NU, Kichula ET, Ou SM, Limbutara K, Knepper MA. Chou CL, et al. Am J Physiol Renal Physiol. 2025 Jan 1;328(1):F29-F47. doi: 10.1152/ajprenal.00182.2024. Epub 2024 Nov 7. Am J Physiol Renal Physiol. 2025. PMID: 39508840

See all "Cited by" articles

References

1. Venturini PL, Capitanio GL, Boccardo E, Ferraro R, Rossato P, De CL. The amenorrhoea–galactorrhea syndrome: present diagnostic and therapeutic perspectives. Acta Eur Fertil. 1975;6(4):331–338. - PubMed
1. Matteson EL. Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schonlein, Wegener, Churg and Strauss, Horton, Takayasu, Behcet, and Kawasaki. Arthritis Care Res. 2000;13(4):237–245. - PubMed
1. Lu DW, Katz KA. Declining use of the eponym “Reiter's Syndrome” in the medical literature, 1998-2003. J Am Acad Dermatol. 2005;53(4):720–723. - PubMed
1. Woywodt A, Haubitz M, Haller H, Matteson EL. Wegener’s granulomatosis. Lancet. 2006:367(9519):1362–1366. - PubMed
1. Matteson EL. All medical eponyms should be abandoned. Presse Med. 2008:37(2 Pt 1):250–251. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Collaborators

Affiliations

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Authors

Collaborators

Affiliations

Abstract

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

References

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical